[go: up one dir, main page]

SE9000288D0 - NEW USE - Google Patents

NEW USE

Info

Publication number
SE9000288D0
SE9000288D0 SE9000288A SE9000288A SE9000288D0 SE 9000288 D0 SE9000288 D0 SE 9000288D0 SE 9000288 A SE9000288 A SE 9000288A SE 9000288 A SE9000288 A SE 9000288A SE 9000288 D0 SE9000288 D0 SE 9000288D0
Authority
SE
Sweden
Prior art keywords
new use
ropivacaine
iontophoresis
manufacture
pharmaceutically acceptable
Prior art date
Application number
SE9000288A
Other languages
Swedish (sv)
Inventor
H C A Evers
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9000288A priority Critical patent/SE9000288D0/en
Publication of SE9000288D0 publication Critical patent/SE9000288D0/en
Priority to HU9202444A priority patent/HU210322B/en
Priority to PCT/SE1991/000053 priority patent/WO1991011182A1/en
Priority to CA002073028A priority patent/CA2073028A1/en
Priority to AU72312/91A priority patent/AU650002B2/en
Priority to JP3503925A priority patent/JPH05503704A/en
Priority to EP91903251A priority patent/EP0597833A1/en
Priority to KR1019920701761A priority patent/KR927003530A/en
Priority to NO922645A priority patent/NO922645D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electrotherapy Devices (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Use of a pharmaceutically acceptable salt of ropivacaine for the manufacture of a pharmaceutical preparation for iontophoresis.
SE9000288A 1990-01-26 1990-01-26 NEW USE SE9000288D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9000288A SE9000288D0 (en) 1990-01-26 1990-01-26 NEW USE
HU9202444A HU210322B (en) 1990-01-26 1991-01-24 Process for production of preparations containing ropivacaine for treatment of iontophoresis
PCT/SE1991/000053 WO1991011182A1 (en) 1990-01-26 1991-01-24 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
CA002073028A CA2073028A1 (en) 1990-01-26 1991-01-24 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
AU72312/91A AU650002B2 (en) 1990-01-26 1991-01-24 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
JP3503925A JPH05503704A (en) 1990-01-26 1991-01-24 Use of local anesthetics in the manufacture of pharmaceutical preparations for iontophoresis
EP91903251A EP0597833A1 (en) 1990-01-26 1991-01-24 Use of local anaesthetic agents in the manufacture of pharmaceutical preparations for iontophoresis
KR1019920701761A KR927003530A (en) 1990-01-26 1991-01-24 Use of local anesthetics in the manufacture of pharmaceutical formulations for iontophoresis
NO922645A NO922645D0 (en) 1990-01-26 1992-07-03 USE OF LOCAL ANESTHESIA FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS FOR IONTOPHORESIS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9000288A SE9000288D0 (en) 1990-01-26 1990-01-26 NEW USE

Publications (1)

Publication Number Publication Date
SE9000288D0 true SE9000288D0 (en) 1990-01-26

Family

ID=20378368

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000288A SE9000288D0 (en) 1990-01-26 1990-01-26 NEW USE

Country Status (8)

Country Link
EP (1) EP0597833A1 (en)
JP (1) JPH05503704A (en)
KR (1) KR927003530A (en)
AU (1) AU650002B2 (en)
CA (1) CA2073028A1 (en)
HU (1) HU210322B (en)
SE (1) SE9000288D0 (en)
WO (1) WO1991011182A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6295469B1 (en) 1997-11-14 2001-09-25 Alza Corporation Formulation for electrically assisted delivery of lidocaine and epinephrine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560367B2 (en) * 1983-08-01 1987-04-02 Astra Lakemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same

Also Published As

Publication number Publication date
EP0597833A1 (en) 1994-05-25
HUT65098A (en) 1994-04-28
KR927003530A (en) 1992-12-18
WO1991011182A1 (en) 1991-08-08
HU9202444D0 (en) 1992-10-28
CA2073028A1 (en) 1991-07-27
JPH05503704A (en) 1993-06-17
AU650002B2 (en) 1994-06-09
HU210322B (en) 1995-03-28
AU7231291A (en) 1991-08-21

Similar Documents

Publication Publication Date Title
NO904694D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES.
NO914667D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ARYLED DERIVATIVES
NO901684L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-SUBSTITUTED-2-OXINDOL DERIVATIVES.
ITMI913324A0 (en) PHARMACEUTICAL AGENTS
DK0535034T3 (en) Pharmaceutically active benzoquinazoline compounds
SE9003057D0 (en) NEW PROCESS
EE9700168A (en) Bicyclic isothiourea derivatives for therapeutic use
ITMI910456A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CATARACT
NO884176D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMIDINO DERIVATIVES.
FI930674A7 (en) Therapeutic agents
ES2113345T3 (en) TREATMENT OF CARDIAC DYSFUNCTION WITH THE HELP OF COMPOUNDS 15-CETO-PROSTAGLANDINA.
KR930702990A (en) Prostacyclin- and carbacycline derivatives for the treatment of fibrotic diseases
SE9000624D0 (en) NEW USE
NO881884L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRROLIDINE DERIVATIVES.
SE9000288D0 (en) NEW USE
FI925518L (en) Process for the preparation of therapeutically active 1-piperidinyl alkanoyl aryl sulfonamide derivatives
MX9207407A (en) IMPROVING THE BIOAVAILABILITY OF PROTEOLITICALLY LABIL THERAPEUTIC AGENTS.
SE9000948D0 (en) NEW USE
NO900972D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE NAFTALEN DERIVATIVES.
NO900942D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AZACYCLOOKTADIEN DERIVATIVES.
FI950010L (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of viral diseases
FI930097A7 (en) Dosage form for administering the drug for the implementation of daily therapy
NO923082L (en) THERAPEUTIC AGENTS
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
SE8702227D0 (en) NEW USE